Development of a patient-reported outcome (PRO) measure for assessing non-small cell lung cancer (NSCLC) symptoms in clinical trials: Interim report from the PRO Consortium’s NSCLC Working Group (WG).

Small Cell ◽

Interim Report ◽

Small Cell Lung ◽

HSR21-067: What Patient-Reported Outcomes Are Being Used in Non-small Cell Lung Cancer? A Targeted Literature Review of Randomized Clinical Trials and Regulatory Labeling

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2020.7726 ◽

2021 ◽

Vol 19 (3.5) ◽

pp. HSR21-067

Author(s):

Kajal Patel ◽

Soham Shukla ◽

Jennifer Hanlon ◽

Kelly Bell ◽

Laurie Eliason ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Randomized Clinical Trials ◽

Small Cell ◽

Small Cell Lung ◽

Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important?

World Journal of Clinical Oncology ◽

10.5306/wjco.v4.i4.82 ◽

2013 ◽

Vol 4 (4) ◽

pp. 82 ◽

Cited By ~ 8

Author(s):

Vera Hirsh

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

PCN270 DEVELOPING A PATIENT-REPORTED OUTCOME MEASURE TO CAPTURE ADVERSE EVENTS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

Value in Health ◽

10.1016/j.jval.2019.04.391 ◽

2019 ◽

Vol 22 ◽

pp. S108

Author(s):

J. Bell ◽

M. Jean-Baptiste ◽

D.A. Revicki ◽

H. Andrews ◽

G. Simon ◽

...

Keyword(s):

Lung Cancer ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Outcome Measure ◽

Small Cell ◽

Small Cell Lung ◽

Patient Reported Outcome Measure ◽

P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients with Metastatic Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1670 ◽

2018 ◽

Vol 13 (10) ◽

pp. S907-S908

Author(s):

L. Williams ◽

S. Dibaj ◽

S. Chandwani ◽

V. Vaghani ◽

Q. Shi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Outcome Assessment ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Small Cell Lung ◽

Development Of A Patient-Reported Outcome (Pro) Assessment Of Core Non-Small Cell Lung Cancer (Nsclc) Symptoms

Value in Health ◽

10.1016/j.jval.2015.09.1250 ◽

2015 ◽

Vol 18 (7) ◽

pp. A471

Author(s):

K DeBusk ◽

N Johnson ◽

C Evans ◽

A Sandler ◽

SS Ramalingam ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Patient-reported outcome measures in definitive chemoradiation for non-small cell lung cancer

Translational Lung Cancer Research ◽

10.21037/tlcr.2019.10.06 ◽

2020 ◽

Vol 9 (1) ◽

pp. 4-7

Author(s):

Khinh Ranh Voong ◽

Josephine L. Feliciano

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Outcome Measures ◽

Cell Lung Cancer ◽

Patient Reported Outcome Measures ◽

Small Cell ◽

Small Cell Lung ◽

Definitive Chemoradiation ◽

Epirubicin in extensive small-cell lung cancer: A phase II study in previously untreated patients: A National Cancer Institute of Canada Clinical Trials Group Study

Lung Cancer ◽

10.1016/0169-5002(90)90224-a ◽

1990 ◽

Vol 6 (3-4) ◽

pp. 139

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

National Cancer Institute ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung

Single agent activity of rhizoxin in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials group

Lung Cancer ◽

10.1016/0169-5002(96)84393-5 ◽

1996 ◽

Vol 15 (1) ◽

pp. 155

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Single Agent ◽

Small Cell ◽

Small Cell Lung

Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours

ESMO Open ◽

10.1016/j.esmoop.2021.100113 ◽

2021 ◽

Vol 6 (3) ◽

pp. 100113

Author(s):

L. Paz-Ares ◽

F. Barlesi ◽

S. Siena ◽

M.-J. Ahn ◽

A. Drilon ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Solid Tumours ◽

Small Cell Lung ◽

138PD_PR Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(18)30412-x ◽

2018 ◽

Vol 13 (4) ◽

pp. S80-S81 ◽

Cited By ~ 1

Author(s):

M. Perol ◽

S. Peters ◽

N. Pavlakis ◽

E. Levchenko ◽

M. Platania ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Patient Reported ◽

Phase Iii Study